Colorectal cancer metastatic phenotype stimulates production by fibroblasts of N-terminal peptide of type III collagen: clinical implications for prognosis
- 25 September 2001
- journal article
- Published by Elsevier in Clinica Chimica Acta
- Vol. 312 (1-2) , 135-142
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Genetic Abnormalities and Microsatellite Instability in Colorectal CancerCancer Detection Prevention, 1998
- Level of α-catenin expression in colorectal cancer correlates with invasiveness, metastatic potential, and survivalJournal of Surgical Oncology, 1998
- Mutation of the transforming growth factor-β type II receptor gene in right-sided colorectal cancer: relationship to clinicopathological features and genetic alterationsThe Journal of Pathology, 1998
- Allele loss, replication errors and loss of expression of E-cadherin in colorectal cancers.Gut, 1997
- High levels of transforming growth factor beta 1 in patients with colorectal cancer: Association with disease progressionGastroenterology, 1996
- Level of expression of E-cadherin mRNA in colorectal cancer correlates with clinical outcomeBritish Journal of Cancer, 1995
- Neoplastic progression of human colorectal cancer is associated with overexpression of the stromelysin‐3 and BM‐40/SPARC genesInternational Journal of Cancer, 1995
- Molecular and cellular basis of cancer invasion and metastasis: Implications for treatmentBritish Journal of Surgery, 1994
- MUC1 mucin expression as a marker of progression and metastasis of human colorectal carcinomaGastroenterology, 1994
- Increased fibronectin-receptor expression in colon carcinoma-derived HT 29 cells decreases tumorigenicity in nude miceGastroenterology, 1994